HighAges 30–60

Personalized Medicine Future Portfolio

Investing in precision medicine, genetic testing, and individualized therapeutic treatments

Expected Return

11-15% annually

Expected Dividend

0.3% annually

Rebalancing

Monthly

Asset Allocation

ARKG (30%)

GNOM (25%)

EDOC (20%)

XBI (15%)

TDOC (10%)

ARKG

Genomic medicine and biotechnology

30%

GNOM

Genetic diagnostics and sequencing

25%

EDOC

Digital health and connected care

20%

XBI

Biotech

15%

TDOC

Telehealth and remote patient monitoring

10%

Advantages

✓At the forefront of a medical revolution
✓Higher treatment efficacy driving adoption and reimbursement
✓Long-term cost reduction potential for healthcare systems

Risks

!Regulatory approval delays can stall commercialization
!Significant ethical and bioethics-related controversies
!High development costs with uncertain commercial outcomes

Allocation by Investment Amount

If investing $1,000

ARKG$300

GNOM$250

EDOC$200

XBI$150

TDOC$100

If investing $5,000

ARKG$1500

GNOM$1250

EDOC$1000

XBI$750

TDOC$500

If investing $10,000

ARKG$3000

GNOM$2500

EDOC$2000

XBI$1500

TDOC$1000